SEC Form 4 · accession 0001567619-18-001854
Astrana Health, Inc. · ASTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adrian Vazquez
Officer — Co-Chief Medical Officer
Period of report
Aug 24, 2018
Accepted (ET)
Aug 28, 2018 · 6:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001083446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 24, 2018 | M | 30,000 | $1.50 | A | 942,338 | D | |
| Common Stock | Aug 24, 2018 | M | 10,000 | $10.00 | A | 952,338 | D | |
| Common Stock | Aug 24, 2018 | M | 18,574 | $6.37 | A | 970,912 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $1.50 | Aug 24, 2018 | M | 30,000 | A | Dec 9, 2010 | Dec 8, 2020 | Common Stock | 30,000 | 33,400 | D |
| Stock Option (right to buy)F2 | $10.00 | Aug 24, 2018 | M | 10,000 | A | Jul 10, 2014 | Jul 10, 2024 | Common Stock | 10,000 | 23,400 | D |
| Stock Option (right to buy)F3 | $6.37 | Aug 24, 2018 | M | 18,574 | A | Sep 14, 2016 | Feb 14, 2021 | Common Stock | 18,574 | 4,826 | D |
Explanation of responses
- F1One third (1/3) of the shares subject to the option vested on December 9, 2010, December 9, 2011 and December 9, 2012, respectively.
- F2One thirty-sixth (1/36) of the shares subject to the option vested on July 10, 2014 and on each monthly anniversary of July 10, 2014, respectively.
- F3The option was approved by the Issuer's Compensation Committee on February 15, 2016, subject to shareholder approval of the plan under which the option was granted. The Issuer's stockholders approved the plan on September 14, 2016. The option vested as to 15,584 shares on February 15, 2016 and the balance of the shares subject to the option vested at a rate of approximately 651 shares per month commencing on March 15, 2016.
Remarks
The acquisition of the Issuer's common stock reported on this Form 4 resulted from the exercise of options granted by the Issuer's Compensation Committee, a committee solely composed of two or more non-employee directors, and is therefore exempt from section 16(b) of the Securities Exchange Act of 1934, as amended, pursuant to rule 16b-3(d)(1) thereunder.